IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 11

Issue Published : 118

Article Submitted : 21495

Article Published : 8513

Total Authors : 22399

Total Reviewer : 805

Total Countries : 158

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Evaluation of WHO Multi-Drug Therapy (MDT) Outcomes and Side Effects in Leprosy Patients at CGMCH, Chidambaram
Authors Name: SURIYAPRAKASH M , Dr.P.K.KAVIARASAN , Dr.C.K.DHANAPAL , SHENBAGAM R , HARIKISHORE M
Download E-Certificate: Download
Author Reg. ID:
IJRTI_200031
Published Paper Id: IJRTI2412012
Published In: Volume 9 Issue 12, December-2024
DOI:
Abstract: Background Leprosy is a chronic infectious disease caused by Mycobacterium leprae, affecting the skin, peripheral nerves, and other tissues. Despite advances in treatment, leprosy remains a public health challenge in endemic areas. The WHO-recommended Multi-Drug Therapy (MDT) has significantly reduced the disease burden, but associated side effects and treatment outcomes require further evaluation. Objective This study aims to assess the side effects, outcomes, and demographic factors influencing the treatment of leprosy patients undergoing WHO MDT at CGMCH, Chidambaram. Method A prospective study was conducted over six months on 50 leprosy patients receiving MDT. Data were collected using structured questionnaires and patient records, including demographics, treatment duration, types of leprosy, and side effects. Statistical analysis was performed to compare pre- and post-training knowledge and attitudes toward leprosy. Result The study population comprised 62% males and 38% females, predominantly aged 31-50 years (38%). Multibacillary leprosy was observed in 62% of patients. Significant improvements were noted in patients’ knowledge and attitudes post-training (p < 0.05). The most common treatment outcomes were improvement in skin lesions and sensation (56%) and unchanged lesions with anesthesia (22%). Side effects included neuropathic pain (10%), type I reaction (8%), and type II reaction (6%), while 62% of patients reported no side effects.Our study concluded that there was decrease in the infection and mortality rate after the administration of prophylactic antibiotics in debridement surgery for burn patients but improvements were needed to use prophylactic antibiotics more precisely regarding quantity and choice of the type of antibiotics.
Keywords: Leprosy, WHO Multi-Drug Therapy, Treatment Outcomes, Side Effects, CGMCH, Chidambaram
Cite Article: "Evaluation of WHO Multi-Drug Therapy (MDT) Outcomes and Side Effects in Leprosy Patients at CGMCH, Chidambaram", International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2455-2631, Vol.9, Issue 12, page no.a109-a115, December-2024, Available :http://www.ijrti.org/papers/IJRTI2412012.pdf
Downloads: 000726
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2412012
Registration ID:200031
Published In: Volume 9 Issue 12, December-2024
DOI (Digital Object Identifier):
Page No: a109-a115
Country: CHIDAMBARAM, TAMILNADU, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2412012
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2412012
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner